TransMedics (TMDX) Net Cash Flow (2018 - 2026)

TransMedics has reported Net Cash Flow for 9 years, with the latest figure at -$8.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 68.87% year-over-year to -$8.4 million; the trailing twelve-month figure through Mar 2026 stood at $168.9 million (up 521.65% YoY), and the FY2025 full-year result was $150.4 million, up 361.07% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$8.4 million, down from $22.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $386.8 million in Q2 2023, with the low at -$155.2 million in Q3 2023.
• Average Net Cash Flow over 5 years is $26.7 million, with a median of -$3.7 million recorded in 2022.
• Year-over-year, Net Cash Flow jumped 6821.28% in 2022 and tumbled 772.79% in 2023.
• Tracing TMDX's Net Cash Flow over 5 years: stood at -$3.7 million in 2022, then plunged by 772.79% to -$32.6 million in 2023, then surged by 122.22% to $7.2 million in 2024, then surged by 205.09% to $22.1 million in 2025, then plunged by 137.84% to -$8.4 million in 2026.
• The last three Net Cash Flow figures came in at -$8.4 million (Q1 2026), $22.1 million (Q4 2025), and $65.6 million (Q3 2025), per Business Quant data.

Peer Comparison